MASTERINVEST Kapitalanlage GmbH Invests $2.46 Million in UnitedHealth Group Incorporated $UNH

MASTERINVEST Kapitalanlage GmbH purchased a new position in shares of UnitedHealth Group Incorporated (NYSE:UNHFree Report) during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 7,897 shares of the healthcare conglomerate’s stock, valued at approximately $2,464,000.

A number of other institutional investors have also made changes to their positions in the company. TT Capital Management LLC acquired a new stake in UnitedHealth Group during the 2nd quarter valued at $489,000. Stance Capital LLC acquired a new stake in shares of UnitedHealth Group during the second quarter valued at about $1,297,000. Pathway Financial Advisers LLC increased its position in shares of UnitedHealth Group by 6.8% during the second quarter. Pathway Financial Advisers LLC now owns 7,221 shares of the healthcare conglomerate’s stock worth $2,253,000 after acquiring an additional 457 shares during the last quarter. North Dallas Bank & Trust Co. purchased a new position in UnitedHealth Group in the second quarter valued at about $1,329,000. Finally, Forefront Wealth Partners LLC increased its holdings in UnitedHealth Group by 6.3% during the 2nd quarter. Forefront Wealth Partners LLC now owns 1,114 shares of the healthcare conglomerate’s stock worth $348,000 after purchasing an additional 66 shares during the last quarter. 87.86% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

UNH has been the subject of a number of recent analyst reports. Wells Fargo & Company raised their price target on shares of UnitedHealth Group from $267.00 to $400.00 and gave the stock an “overweight” rating in a research report on Tuesday, October 7th. Truist Financial boosted their target price on shares of UnitedHealth Group from $310.00 to $365.00 and gave the stock a “buy” rating in a research report on Tuesday, September 9th. KeyCorp increased their price target on shares of UnitedHealth Group from $350.00 to $400.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 8th. UBS Group upped their price objective on UnitedHealth Group from $378.00 to $430.00 and gave the company a “buy” rating in a research note on Wednesday, October 29th. Finally, Mizuho boosted their price target on UnitedHealth Group from $300.00 to $430.00 and gave the company an “outperform” rating in a report on Thursday, October 9th. Seventeen investment analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and three have issued a Sell rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus target price of $385.54.

Check Out Our Latest Stock Report on UNH

UnitedHealth Group Stock Up 1.5%

NYSE:UNH opened at $341.83 on Monday. The firm has a market capitalization of $309.65 billion, a PE ratio of 17.84, a price-to-earnings-growth ratio of 2.23 and a beta of 0.43. UnitedHealth Group Incorporated has a 52 week low of $234.60 and a 52 week high of $606.36. The company has a current ratio of 0.82, a quick ratio of 0.82 and a debt-to-equity ratio of 0.71. The stock has a 50 day moving average of $339.84 and a 200-day moving average of $317.20.

UnitedHealth Group (NYSE:UNHGet Free Report) last issued its quarterly earnings data on Tuesday, October 28th. The healthcare conglomerate reported $2.92 EPS for the quarter, topping analysts’ consensus estimates of $2.87 by $0.05. The firm had revenue of $113.16 billion during the quarter, compared to the consensus estimate of $113.19 billion. UnitedHealth Group had a return on equity of 19.23% and a net margin of 4.04%.The firm’s revenue was up 12.2% on a year-over-year basis. During the same period in the prior year, the business earned $7.15 EPS. Analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, December 16th. Shareholders of record on Monday, December 8th will be paid a dividend of $2.21 per share. This represents a $8.84 dividend on an annualized basis and a yield of 2.6%. The ex-dividend date of this dividend is Monday, December 8th. UnitedHealth Group’s payout ratio is presently 46.14%.

UnitedHealth Group Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Featured Stories

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.